Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Pivot Pharmaceuticals Inc. PVOTF

MissionIRNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Subsidiary Enters Manufacturing and Supply Agreement in California

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that its wholly-owned California subsidiary, Pivot Naturals, LLC, has signed a definitive manufacturing and supply agreement with Stoney LLC, a leading brand of cannabis products … Continue reading

Posted in MissionIRNewsBreaks, Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) Aims for Rapid Delivery of Cancer, Skin, Female Sexual Dysfunction Therapies

Pivot developing nutraceutical and pharmaceutical therapies based on cannabis derivatives Female sexual dysfunction market expected to exceed booming male products market Skin and oral delivery of Pivot products driven by innovative technologies The advent of modern licensing controls for over-the-counter … Continue reading

Posted in Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

MissionIRNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Posts Shareholder Update

Pivot Pharmaceuticals (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning provided an update to shareholders regarding the current state of the company. Among other highlights, the update included an overview of Pivot’s plans to generate value for the company and … Continue reading

Posted in MissionIRNewsBreaks, Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

MissionIRNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Leverages Innovative Technologies for Improved Cannabinoid Product Delivery

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) holds significant patents and a cannabinoid product portfolio designed with disruptive technologies that strive to maximize bioavailability, stability and drug release rates. A recent article highlights PVOTF’s innovative delivery technologies, indicating, … Continue reading

Posted in MissionIRNewsBreaks, Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

MissionIRNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Targets Several Indications with Wide-ranging Product Pipeline

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) that currently has numerous pharmaceutical and nutraceutical products in its development pipeline. An article discussing the company reads: “Pivot has a number of products in its pipeline that are … Continue reading

Posted in MissionIRNewsBreaks, Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

MissionIRNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Holds Promising Position in Expanding Cannabis Space

With its proven pharmaceutical and patented formulation and delivery technologies, Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) holds a favorable position in an expanding vertical of the cannabis industry. An article discussing the company reads: … Continue reading

Posted in MissionIRNewsBreaks, Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

MissionIRNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Terminates LOI for the Acquisition of Agro-Biotech

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning reported that it has terminated the previously announced letter of intent (“LOI”) that it had entered into for the acquisition of Agro-Biotech. The company is currently … Continue reading

Posted in MissionIRNewsBreaks, Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

MissionIRNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Entering Multi-billion-dollar Industries through Strategic Acquisitions

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) is developing disruptive formulations for cannabis-infused markets. An article discussing the company reads: “Pivot’s acquisition of California’s ERS Holdings, LLC in February not only strengthened its options for … Continue reading

Posted in MissionIRNewsBreaks, Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Provides Update on Bio-Cannabis Product Pipeline

Several proprietary products developed and ready to market in Canada, California and global markets Cannabis product sales expected to generate significant revenue Pivot’s IP portfolio includes global patents to cement its leading position in the cannabis industry On April 4, … Continue reading

Posted in Pivot Pharmaceuticals Inc. PVOTF | Leave a comment

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Extracts Maximum Benefit from Cannabis Portfolio

Forecasts predict $55.8 billion valuation for medical cannabis market by 2025 Pivot Pharmaceuticals building portfolio of diverse tech for improving bioavailability of cannabinoid therapies Company’s leadership team builds on decades of experience in pharmaceutical arena For nutrition-conscious consumers, scanning food … Continue reading

Posted in Pivot Pharmaceuticals Inc. PVOTF | Leave a comment